BACKGROUND: The renin-angiotensin system is involved in the development of hypertension, atherosclerosis and cardiovascular disease. We studied the association between the M235T polymorphism of the angiotensinogen gene (AGT) and the C573T polymorphism of the angiotensin II type 1 receptor (AT1R) and blood pressure, carotid atherosclerosis and cerebrovascular disease. METHODS: We genotyped over 6000 subjects from the Rotterdam Study and more than 1000 subjects from the Rotterdam Scan Study. We used logistic regression and univariate analyses, adjusting for age and sex with, for AGT, the MM and, for AT1R, the TT genotype as reference. RESULTS: We found that AGT-235T increased systolic (p for trend = 0.03) and diastolic blood pressure (p for trend = 0.04). The prevalence of carotid plaques was increased 1.25-fold (95% CI 1.02-1.52) in AGT-TT carriers. There was a significant increase in mean volume deep subcortical white matter lesions (WML) for AGT-TT carriers (1.78 ml vs 1.09 ml in the reference group; p = 0.008). A significant interaction was found between AGT and AT1R, further increasing the effect on periventricular and subtotal WML (p for interaction = 0.02). We found a non-significant increased risk of silent brain infarction for AGT-TT carriers and AT1R-CC carriers, but no effect on stroke. CONCLUSION: We found an association between AGT and blood pressure, atherosclerosis and WML. Also, we found synergistic effects between AGT and AT1R on the development of WML. These findings raise the question of whether the renin-angiotensin system may be a therapeutic target for the prevention of cerebral white matter pathology.
BACKGROUND: The renin-angiotensin system is involved in the development of hypertension, atherosclerosis and cardiovascular disease. We studied the association between the M235T polymorphism of the angiotensinogen gene (AGT) and the C573T polymorphism of the angiotensin II type 1 receptor (AT1R) and blood pressure, carotid atherosclerosis and cerebrovascular disease. METHODS: We genotyped over 6000 subjects from the Rotterdam Study and more than 1000 subjects from the Rotterdam Scan Study. We used logistic regression and univariate analyses, adjusting for age and sex with, for AGT, the MM and, for AT1R, the TT genotype as reference. RESULTS: We found that AGT-235T increased systolic (p for trend = 0.03) and diastolic blood pressure (p for trend = 0.04). The prevalence of carotid plaques was increased 1.25-fold (95% CI 1.02-1.52) in AGT-TT carriers. There was a significant increase in mean volume deep subcortical white matter lesions (WML) for AGT-TT carriers (1.78 ml vs 1.09 ml in the reference group; p = 0.008). A significant interaction was found between AGT and AT1R, further increasing the effect on periventricular and subtotal WML (p for interaction = 0.02). We found a non-significant increased risk of silent brain infarction for AGT-TT carriers and AT1R-CC carriers, but no effect on stroke. CONCLUSION: We found an association between AGT and blood pressure, atherosclerosis and WML. Also, we found synergistic effects between AGT and AT1R on the development of WML. These findings raise the question of whether the renin-angiotensin system may be a therapeutic target for the prevention of cerebral white matter pathology.
Authors: S Takami; Y Imai; T Katsuya; T Ohkubo; I Tsuji; K Nagai; H Satoh; S Hisamichi; J Higaki; T Ogihara Journal: Am J Hypertens Date: 2000-02 Impact factor: 2.689
Authors: Thaís S C Minett; Jennie L Dean; Michael Firbank; Philip English; John T O'Brien Journal: Am J Geriatr Psychiatry Date: 2005-08 Impact factor: 4.105
Authors: R Schmidt; H Schmidt; F Fazekas; L J Launer; K Niederkorn; P Kapeller; A Lechner; G M Kostner Journal: Hypertension Date: 2001-07 Impact factor: 10.190
Authors: Lauren E Salminen; Peter R Schofield; Kerrie D Pierce; Yi Zhao; Xi Luo; Youdan Wang; David H Laidlaw; Ryan P Cabeen; Thomas E Conturo; David F Tate; Erbil Akbudak; Elizabeth M Lane; Jodi M Heaps; Jacob D Bolzenius; Laurie M Baker; Lee M Cagle; Robert H Paul Journal: Behav Brain Res Date: 2015-08-28 Impact factor: 3.332
Authors: R R Lemos; S G de Lima; J E Gomes da Cunha; D F Oliveira; M B Rodrigues de Souza; C F J Ayres; M F P M Albuquerque; J R M Oliveira Journal: J Mol Neurosci Date: 2012-04-25 Impact factor: 3.444
Authors: A Vilar-Bergua; I Riba-Llena; C Nafría; A Bustamante; V Llombart; P Delgado; J Montaner Journal: J Cereb Blood Flow Metab Date: 2016-01 Impact factor: 6.200
Authors: Warren D Taylor; Sophiya Benjamin; Douglas R McQuoid; Martha E Payne; Ranga R Krishnan; James R MacFall; Allison Ashley-Koch Journal: Psychiatry Res Date: 2012-06-15 Impact factor: 3.222
Authors: Oana Mocan; Elena Buzdugan; Angela Cozma; Daniel Corneliu Leucuta; Dan Radulescu; Lucia Maria Procopciuc Journal: In Vivo Date: 2020 Sep-Oct Impact factor: 2.155
Authors: Edith Hofer; Margherita Cavalieri; Joshua C Bis; Charles DeCarli; Myriam Fornage; Sigurdur Sigurdsson; Velandai Srikanth; Stella Trompet; Benjamin F J Verhaaren; Christiane Wolf; Qiong Yang; Hieab H H Adams; Philippe Amouyel; Alexa Beiser; Brendan M Buckley; Michele Callisaya; Ganesh Chauhan; Anton J M de Craen; Carole Dufouil; Cornelia M van Duijn; Ian Ford; Paul Freudenberger; Rebecca F Gottesman; Vilmundur Gudnason; Gerardo Heiss; Albert Hofman; Thomas Lumley; Oliver Martinez; Bernard Mazoyer; Chris Moran; Wiro J Niessen; Thanh Phan; Bruce M Psaty; Claudia L Satizabal; Naveed Sattar; Sabrina Schilling; Dean K Shibata; P Eline Slagboom; Albert Smith; David J Stott; Kent D Taylor; Russell Thomson; Anna M Töglhofer; Christophe Tzourio; Mark van Buchem; Jing Wang; Rudi G J Westendorp; B Gwen Windham; Meike W Vernooij; Alex Zijdenbos; Richard Beare; Stéphanie Debette; M Arfan Ikram; J Wouter Jukema; Lenore J Launer; W T Longstreth; Thomas H Mosley; Sudha Seshadri; Helena Schmidt; Reinhold Schmidt Journal: Stroke Date: 2015-10-08 Impact factor: 7.914